TrialPharmacology research & perspectives2018

The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects.

Mark Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.